News and Announcements
Bitcoin Australia raises $3 million from one of the world’s largest crypto exchanges
- Published September 10, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- KuCoin invests $3 million in Bitcoin Australia in a bid to expand its current activities.
- The partnership between KuCoin and Bitcoin Australia will appeal to all levels of investors from entry level to advanced investors.
- BitCoin will look to expand from the current three to thirty markets over the next two years.
KuCoin, one of the world’s largest cryptocurrency exchanges, has invested $3 million into Bitcoin Australia in a bid to enter the local market and kickstart its international expansion. Bitcoin Australia CEO, Rupert Hackett identified the clear synergies between KuCoin, who target sophisticated investors, and Bitcoin Australia, who aim to make cryptocurrency
trading available to all Australians.
The result is an exchange for all traders – with Bitcoin continuing to appeal as a consumer-friendly experience for new traders, and KuCoin targeting seasoned intermediate and advanced investors. KuCoin currently boats 4 million users, employs 300 people and transacts $US500 million per month.
Established in 2015, the KuCoin and Bitcoin Australia partnership is looking to expand from the current three markets to thirty over the next two years. The initial target is building the brand in the UK market and other European and Canadian locations. With the recent slowdown in trade, Bitcoin is focussing on raising money through more traditional methods as opposed to an initial coin offering, in a bid to build trust in the platform.
To be part of Bitcoin Australia’s growth, register your interest at the button below.
About Bitcoin Australia
Bitcoin Australia is one of Australia’s fastest growing crypto exchanges, allowing users to buy and sell Bitcoin and Ethereum instantly and securely.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
